Bio-Techne launches iPSC expansion medium

By The Science Advisory Board staff writers

September 14, 2021 -- Bio-Techne has unveiled ExCellerate iPSC Expansion Medium, a new medium to support the expansion and maintenance of induced pluripotent stem cells (iPSCs) for research and translational applications.

ExCellerate is designed for regenerative medicine, including stem cell workflows such as cell isolation, reprogramming, genome engineering, cell expansion, differentiation, and characterization, according to the company. It is not made with any components derived from animals or humans and is ideally suited for use in translational research to produce iPSC-based cell and gene therapies, Bio-Techne said.

Bio-Techne reports organic revenue growth for Q4
Bio-Techne reported an organic revenue increase of 39% for the fourth quarter of 2021.
Bio-Techne, Progen launch Simple Plex AAV2 immunoassay
Bio-Techne and Progen have launched the Simple Plex adeno-associated virus 2 (AAV2) viral titer assay for AAV2 total capsid quantification.
Bio-Techne launches multiplex spatial genomics assay
Bio-Techne has expanded its RNAscope in situ hybridization technology portfolio with the release of the new RNAscope HiPlex V2 assay for formalin-fixed,...
Bio-Techne opens new facility in Ireland
Bio-Techne has opened a new facility in Dublin as part of its efforts to support the life sciences industry in Europe.
Catamaran Bio, Bio-Techne expand CAR-NK cell collaboration
Catamaran Bio and Bio-Techne have expanded their collaboration on the development of cell engineering and cell process technologies for Catamaran's manufacturing...

Copyright © 2021 scienceboard.net


Conferences
Bio-IT World Conference and Expo
September 20-22
Boston, Massachusetts United States
BioProcess International
September 20-23
Boston, Massachusetts United States
Cell and Gene Therapy Manufacturing and Commercialization
September 20-23
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter